MedPath

Exercise Training and Inflammatory Mediators in COPD

Not Applicable
Completed
Conditions
COPD
Interventions
Other: Resistance Training RT
Other: Endurance Training ET
Registration Number
NCT03853174
Lead Sponsor
Faculty of Medicine, Sousse
Brief Summary

Chronic obstructive pulmonary disease (COPD) is widely spread all over the world. It is predicted to be the third leading cause of death by 2020\[1\]. COPD is a common, preventable treatable disease that is characterized by an airflow limitation which is not fully reversable\[2\].

Detailed Description

Chronic obstructive pulmonary disease (COPD) is widely spread all over the world. It is predicted to be the third leading cause of death by 2020. COPD is a common, preventable treatable disease that is characterized by an airflow limitation which is not fully reversable.Not only the long-term exposition to noxious particles and gases contributes to the development of COPD, but also so many others factors such as genetics and cigarette smoking. It has been shown that cigarettes are harmful and contributed to different extra pulmonary disorders. Indeed, it induced a systemic inflammation that was considered as a key process in the pathogenesis of COPD and triggered the activation of inflammatory cells and an abnormal increase of circulating cytokines such as CRP, interleukin (IL6), IL8, tumor necrosis factor alpha (TNF alpha) and leptin.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
28
Inclusion Criteria
  • COPD diagnosed by pulmonary function testing
  • Clinically stable
  • Abscence of other obstructive diseases
  • Signed written consent
Exclusion Criteria
  • Neuromuscular diseases -Severe psychiatric, neurologic or musculoskeletal conditions and /or instable--- --
  • cardiovascular diseases.
  • Contre-indications to physical therapy
  • Acute exacerbations a month before the intervention

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RTResistance Training RTResistance training were prformed. Intensity was gradually increased.
ETEndurance Training ETActive Comparator: ET Endurance training were prformed. Intensity was gradually increased.
Primary Outcome Measures
NameTimeMethod
Enzyme linked immunosorbent assay for serum cytokines levels changeBaseline, 6 months

The interleukines were determined by ELISA assays with commercial kits

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Amal Acheche

🇹🇳

Sousse, Tunisia

© Copyright 2025. All Rights Reserved by MedPath